203 related articles for article (PubMed ID: 7642465)
1. Multidrug resistance in pediatric malignancies.
Chan HS; DeBoer G; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1995 Apr; 9(2):275-318. PubMed ID: 7642465
[TBL] [Abstract][Full Text] [Related]
2. Multidrug drug resistance in pediatric sarcomas.
Chan HS; DeBoer G; Haddad G; Ling V
Hematol Oncol Clin North Am; 1995 Aug; 9(4):889-908. PubMed ID: 7490247
[TBL] [Abstract][Full Text] [Related]
3. Multidrug resistance. Clinical opportunities in diagnosis and circumvention.
Chan HS; DeBoer G; Thorner PS; Haddad G; Gallie BL; Ling V
Hematol Oncol Clin North Am; 1994 Apr; 8(2):383-410. PubMed ID: 7913705
[TBL] [Abstract][Full Text] [Related]
4. P-glycoprotein in adult solid tumors. Expression and prognostic significance.
Leighton JC; Goldstein LJ
Hematol Oncol Clin North Am; 1995 Apr; 9(2):251-73. PubMed ID: 7642464
[TBL] [Abstract][Full Text] [Related]
5. Clinical studies with modulators of multidrug resistance.
Fisher GA; Sikic BI
Hematol Oncol Clin North Am; 1995 Apr; 9(2):363-82. PubMed ID: 7642468
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the expression and function of multidrug resistance transporter proteins in acute myeloid leukemia: studies of the Southwest Oncology Group Leukemia Research Program.
Willman CL
Semin Hematol; 1997 Oct; 34(4 Suppl 5):25-33. PubMed ID: 9408958
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance: clinical relevance in solid tumours and strategies for circumvention.
Kaye SB
Curr Opin Oncol; 1998 Aug; 10 Suppl 1():S15-9. PubMed ID: 9801854
[TBL] [Abstract][Full Text] [Related]
8. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia.
Wuchter C; Leonid K; Ruppert V; Schrappe M; Büchner T; Schoch C; Haferlach T; Harbott J; Ratei R; Dörken B; Ludwig WD
Haematologica; 2000 Jul; 85(7):711-21. PubMed ID: 10897123
[TBL] [Abstract][Full Text] [Related]
10. A sensitive multilayer immunoalkaline phosphatase method for detection of P-glycoprotein in leukemic and tumor cells in the bone marrow.
Haddad G; Thorner PS; Bradley G; Dalton WS; Ling V; Chan HS
Lab Invest; 1994 Oct; 71(4):595-603. PubMed ID: 7967514
[TBL] [Abstract][Full Text] [Related]
11. Modulators of multidrug resistance. Preclinical studies.
Ford JM
Hematol Oncol Clin North Am; 1995 Apr; 9(2):337-61. PubMed ID: 7642467
[TBL] [Abstract][Full Text] [Related]
12. Flow cytometric determination of the multidrug-resistant phenotype in acute leukemia.
Maslak P; Hegewisch-Becker S; Godfrey L; Andreeff M
Cytometry; 1994 Sep; 17(1):84-93. PubMed ID: 8001461
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
14. Multidrug resistance: molecular and clinical aspects.
Dicato M; Duhem C; Pauly M; Ries F
Cytokines Cell Mol Ther; 1997 Jun; 3(2):91-9. PubMed ID: 9287248
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug resistance-related markers in primary neuroblastoma.
Lu QJ; Dong F; Zhang JH; Li XH; Ma Y; Jiang WG
Chin Med J (Engl); 2004 Sep; 117(9):1358-63. PubMed ID: 15377429
[TBL] [Abstract][Full Text] [Related]
16. Expression of multidrug resistance-1 and multidrug resistance-associated protein genes in pediatric rhabdomyosarcoma.
Gallego S; Llort A; Parareda A; Sanchez De Toledo J
Oncol Rep; 2004 Jan; 11(1):179-83. PubMed ID: 14654923
[TBL] [Abstract][Full Text] [Related]
17. Drug resistance in chemotherapy for breast cancer.
Saeki T; Tsuruo T; Sato W; Nishikawsa K
Cancer Chemother Pharmacol; 2005 Nov; 56 Suppl 1():84-9. PubMed ID: 16273361
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance of testis cancers: the study of clinical relevance of P-glycoprotein expression.
Eid H; Bodrogi I; Csókay B; Oláh E; Bak M
Anticancer Res; 1996; 16(6B):3447-52. PubMed ID: 9042205
[TBL] [Abstract][Full Text] [Related]
19. Multidrug resistance-associated protein in acute myeloid leukemia: No impact on treatment outcome.
Filipits M; Suchomel RW; Zöchbauer S; Brunner R; Lechner K; Pirker R
Clin Cancer Res; 1997 Aug; 3(8):1419-25. PubMed ID: 9815827
[TBL] [Abstract][Full Text] [Related]
20. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts.
Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM
Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]